[1]
|
Glimelius, B., Hoffman, K., Sjoden, P.O., Jacobsson, G., Sellstrom, H., Enander, L.K., Linne, T. and Svensson, C. (1996) Chemotherapy Improves Survival and Quality of Life in Advanced Pancreatic and Biliary Cancer. Annals of Oncology, 7, 593-600. http://dx.doi.org/10.1093/oxfordjournals.annonc. a010676
|
[2]
|
Takada, T., Nimura, Y., Katoh, H., Nagakawa, T., Nakayama, T., Matsushiro, T., Amano, H. and Wada, K. (1998) Prospective Randomized Trial of 5-Flurouracil, Doxorubicin and Mitomycin C for Non-Rescctable Pancreatic and Biliary Carcinoma: Multicenter Randomized Trial. Hepatogstroenterology, 45, 2020-2026.
|
[3]
|
Falkson, G., Mac Intyre, J.M. and Moertel, C.G. (1984) Eastern Cooperative Oncology Group Experience with Chemotherapy for Inoperable Gallbladder and Bile Duct Cancer. Cancer, 54, 985-969.
http://dx.doi.org/10.1002/1097-0142(19840915)54:6<965::AID-CNCR2820540603>3.0.CO;2-X
|
[4]
|
Davis Jr., H.L., Ramirez, G. and Ansfield, F.J. (1974) Adenocarcinomas of Stomach, Pancreas, Liver, and Biliary Tracts. Survival of 328 Patients Treated with Fluoropyrimidine Therapy. Cancer, 33, 193-197.
http://dx.doi.org/10.1002/1097-0142(197401)33:1<193::AID-CNCR2820330128>3.0.CO;2-S
|
[5]
|
Okada, S., Ishii, H., Nose, H., Okusaka, T., Kyogoku, A., Aoki, K., Iwasaki, M., Furuse, J. and Yoshino, M. (1994) A Phase II Study of Cisplatin in Patients with Biliary Tract Carcinoma. Oncology, 51, 515-517.
http://dx.doi.org/10.1159/000227396
|
[6]
|
Ducreux, M., Rougier, P., Fandi, A., Yoshimori, T., Wakabayashi, K., Clavero-Fabri, M.C., Villing, A.L., Fassone, F., Fandi, L., Zarba, J. and Armand, J.P. (1998) Effective Treatment of Advanced Biliary Tract Carcinoma Using 5-Fluorouracil Continuous Infusion with Cisplatin. Annals of Oncology, 9, 653-656.
http://dx.doi.org/10.1023/A:1008241008379
|
[7]
|
Doval, D.C., Shekhon, J.S., Gupta, S.K., Fuloria, J., Shukla, V.K., Gupta, S. and Awasthy, B.K. (2004) A Phase II Study of Gemcitabine and Cisplatin in Chemotherapy—Naive Advanced Unresectable Gall Bladder Cancer. British Journal of Cancer, 90, 1516-1520. http://dx.doi.org/10.1038/sj.bjc.6601736
|
[8]
|
Thongprasert, S., Napapan, S., Charoentum, C. and Moonprakan, S. (2005) Phase II Study of Gemcitabine and Cisplatin as First Line Chemotheraphy in Inoperable Biliary Tract Carcinoma. Annals of Oncology, 16, 279-281.
http://dx.doi.org/10.1093/annonc/mdi046
|
[9]
|
Malik, I.A., Aziz, Z. and Zaidi, Sethumaran, G. (2003) Gemcitabine and Cisplatin Is a Highly Effective Combination Therapy in Patients with Advanced Cancer Gall Bladder. American Journal of Clinical Oncology, 26, 174-177.
http://dx.doi.org/10.1097/00000421-200304000-00015
|
[10]
|
Eng, C., Ramnathan, R.K., Wong, M.K., Ramick, S.C., Dai, L., Wade-Oliver, K.T., Mani, S. and Kindler, H.L. (2004) A Phase II Trial of Fixed Dose Rate Gemictabine in Patients with Advanced Biliary Carcinoma. American Journal of Clinical Oncology, 27, 565-569. http://dx.doi.org/10.1097/01.coc.00 00135924.94955.16
|
[11]
|
Di lauro, L., Carpano, S., Capomolla, E., et al. (1997) Cisplatin, Epirubicin and 5-Fluorouracil (PEF) for Advanced Biliary Tract Carcianoma. American Society of Clinical Oncology, 16, 287 a.
|
[12]
|
Okada, S., Okusaka, T., Ishii, H., et al. (1997) Phase II Trial of Cisplatin, Epirubicinss and Continuous Infusion 5-Fluorouracil (5-FU) (CEF Fherapy) for Advanced Gall Bladder Cancer (GBC). American Society of Clinical Oncology, 16, 301 a.
|
[13]
|
Ellis, P.A., Norman, A., Hill, A., O’Brien, M.E., Nicolson, M., Hickish, T. and Cunningham, D. (1995) Epirubicin, Cisplatin and Infusional 5-Fluorouracil (5-FU) (ECF) in Hepatobiliary Tumours. European Journal of Cancer, 31A, 1594-1598.
|
[14]
|
Ishii, H., Furuse, J., Yonemoto, N., Nagase, M., Yoshino, M. and Sato, T. (2004) Chemotherapy in Treatment of Advanced Gallbladder Cancer. Oncology, 66, 138-142. http://dx.doi.org/10.1159/00 0077440
|
[15]
|
Therasse, P., Arbuck, S.G., Eisenhauer, E.A., Wanders, J., Kaplan, R.S., Rubinstein, L., Verweij, J., Van Glabakke, M., Van Oosterom, A.T., Christian, M.C. and Gyther, S.G. (2000) New Guidelines to Evaluate the Response to Treatment in Solid Tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. Journal of the National Cancer Institute, 92, 205-221.
http://dx.doi.org/10.1093/jnci/92.3.205
|
[16]
|
Gehan, E.A. (1961) The Determination of the Number of Patients Required in a Preliminary and Follow-Up Trial of a New Chemotherapeutic Agent. Journal of Chronic Diseases, 13, 346-353.
http://dx.doi.org/10.1016/0021-9681(61)90060-1
|
[17]
|
Penz, M., Kornek, G.V., Raderer, M., Ulrich-Pur, H., Fiebiger, W., Lenauer, A., Depish, D., Krauss, G., Schneweiss, B. and Scheithauer, W. (2001) Phase II Trial of Two Weekly Gemcitabine in Patients with Advanced Biliary Tract Cancer. Annals of Oncology, 12, 183-186. http://dx.doi.org/10.1023/A:100 8352123009
|
[18]
|
Lin, M.H., Chen, J.S., Chen, H.H. and Su, W.C. (2003) A Phase II Trial of Gemictabine in Treatment of Advanced Bile Duct and Periampullary Carcinomas. Chemotherapy, 49, 154-158. http://dx.doi.org/10.1159/000070622
|
[19]
|
Taieb, J., Mitry, E., Boige, V., Artru, P., Ezenfis, J., Lecomte, T., Claverno-Fabri, M.C., Vaillant, J.N., Rougier, P. and Ducreux, M. (2002) Optimization of 5-Flurouraicl (5-FU)/Cisplatin Combination Chemotherapy with a New Schedule of Leucovorin, 5-FU and Cisplatin (LV5FU 2-P Regimen) in Patients with Biliary Tract Carcinoma. Annals of Oncology, 13, 1192-1196. http://dx.doi.org/10.1093/annonc/mdf201
|
[20]
|
Patt, Y.Z., Hassan, M.M., Lozano, R.D., Waugh, K.A., Hoque, A.M., Frome, A.I., Lahoti, S., Ellis, L., Vauthey, J.N., Curley, S.A., Schnirer, I.I. and Raijman, I. (2001) Phase II Trial of Cisplatin, Interferon Alpha-2 b, Doxorubicin and 5-Fluorouracil for Biliary Tract Cancer. Clinical Cancer Research, 7, 3375-3380.
|
[21]
|
Gupta, S.K., Ansari, M.A. and Shukla, V.K. (2005) What Makes the Gangetic Belt a Fertile Ground for Gallbladder Cancers? Journal of Surgical Oncology (In press), http://dx.doi.org/10.1002/jso.20292
|
[22]
|
Parikh, P.M., Agarwalla, D.K., Malhotra, H., Govindbabu, K., Ranade, A.A., Vaid, A.K., Basade, M. and Bhattacharyya, G.S. (2005) Gallbladder and Biliary Tract Carcinoma—A Comprehensive Medical Management Update. Indian Co-Operative Oncology Network.
|